You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Boehringer Ingelheim
Express Scripts
Dow
Mallinckrodt

Last Updated: May 27, 2020

DrugPatentWatch Database Preview

Fluvoxamine maleate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for fluvoxamine maleate and what is the scope of patent protection?

Fluvoxamine maleate is the generic ingredient in three branded drugs marketed by Actavis Elizabeth, Anchen Pharms, Torrent, Jazz Pharms, Ani Pharms Inc, Apotex, Eci Pharms Llc, Heritage Pharma, Mylan, Sun Pharm Industries, Synthon Pharms, Teva, Upsher Smith Labs, Ani Pharms, and Solvay, and is included in nineteen NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Fluvoxamine maleate has twenty-four patent family members in eighteen countries.

There are eleven drug master file entries for fluvoxamine maleate. Nine suppliers are listed for this compound.

Drug Prices for fluvoxamine maleate

See drug prices for fluvoxamine maleate

Recent Clinical Trials for fluvoxamine maleate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2
Guangdong General HospitalPhase 4
AbbViePhase 3

See all fluvoxamine maleate clinical trials

Recent Litigation for fluvoxamine maleate

Identify potential future generic entrants

District Court Litigation
Case NameDate
Elan Pharma International Limited v. Anchen Pharmaceuticals Inc

See all fluvoxamine maleate litigation

Pharmacology for fluvoxamine maleate
Synonyms for fluvoxamine maleate
(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine; but-2-enedioic acid
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-1-pentanone O-(2-aminoethyl)oxime (Z)-2-butenedioate (1:1)
(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate
(E)-5-methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-2-aminoethyl oxime maleate
(E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl)-1-pent
(E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate
(E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-O-(2-aminoethyl)oxime maleate
(Z)-2-butenedioic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
(Z)-but-2-enedioic acid; 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
(Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1)
1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime,(E)-, (Z)-2-butenedioate (1:1)
1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-,O-(2-aminoethyl)oxime, (1E)-, (2Z)-2-butenedioate (1:1)
1246666-24-9
2-[({(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino)oxy]ethanamine (2Z)-but-2-enedioate
5-Methoxy-1-(4-trifluoromethyl-phenyl)-pentan-1-one O-(2-amino-ethyl)-oxime maleate
5-Methoxy-4'-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1)
5-Methoxy-4'-trifluoromethylvalerophenone (E)-O-2-aminoethyloxime monomaleate
54739-18-3
54739-20-7
5LGN83G74V
61718-82-9
739F183
A833394
AB2000054
AC-9541
AK-51736
AKOS015855869
AKOS015906773
AKOS015961142
AKOS030242722
ANW-64083
API0002751
AS-11790
AX8016087
BCP06470
BG0368
C15H21F3N2O2.C4H4O4
C19H25F3N2O6
CCG-213494
CHEBI:5139
CHEMBL1409
CPD000466268
CS-1839
CTK8C0093
D00824
Depromel
DTXSID3042558
DU-23000
DU23000
EN300-122372
EU-0100495
F 2802
F0858
Faverin
Fevarin
Floxyfral
fluvoxamin e
Fluvoxamine (maleate)
Fluvoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard
Fluvoxamine maleate (JP17/USAN)
Fluvoxamine maleate [USAN:USP]
Fluvoxamine maleate [USAN]
Fluvoxamine maleate, 1.0 mg/mL in methanol ((as free base)), certified reference material
Fluvoxamine maleate, British Pharmacopoeia (BP) Reference Standard
Fluvoxamine maleate, European Pharmacopoeia (EP) Reference Standard
Fluvoxamine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
Fluvoxamine maleate, solid
Fluvoxamine maleate, United States Pharmacopeia (USP) Reference Standard
Fluvoxamine-maleate
Fluvoxaminemaleate
FT-0626496
GP8417
HMS1571G11
HMS2098G11
HMS3261D11
HMS3267A08
HMS3370O21
HMS3371G18
HMS3373J05
HMS3393E15
HMS3412A13
HMS3604H15
HMS3654B17
HMS3676A13
HMS3715G11
HY-B0103A
J90043
KS-00000XLE
KS-1063
LFMYNZPAVPMEGP-PIDGMYBPSA-N
LP00495
LS-102000
Luvox
Luvox (TN)
Luvox CR
MCULE-4841680762
MFCD00269809
MK-264
MLS000028469
MLS000758271
MLS001076285
MLS001304717
MLS001401391
MLS006011983
NCGC00093897-01
NCGC00093897-02
NCGC00261180-01
NE47064
NSC 309469
NSC-309469
NSC-759602
NSC309469
NSC759602
Pharmakon1600-01505604
Q27262521
s1336
SAM001246977
SCHEMBL35225
SCHEMBL782847
SME 3110
SME-3110
SMR000058449
SMR000466268
SMR000653482
SMR004703541
SR-01000075613
SR-01000075613-1
SR-01000075613-3
SR-01000075613-4
SR-01000075613-6
ST24035070
SW197282-4
TC-063925
Tox21_500495
UNII-5LGN83G74V
Z1583164922
Paragraph IV (Patent) Challenges for FLUVOXAMINE MALEATE
Tradename Dosage Ingredient NDA Submissiondate
LUVOX CR CAPSULE, EXTENDED RELEASE;ORAL fluvoxamine maleate 022033 2009-04-20
LUVOX CR CAPSULE, EXTENDED RELEASE;ORAL fluvoxamine maleate 022033 2009-04-13

US Patents and Regulatory Information for fluvoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075897-001 Jan 25, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075897-003 Jan 25, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Ani Pharms LUVOX fluvoxamine maleate TABLET;ORAL 021519-003 Dec 20, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for fluvoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-001 Dec 5, 1994   Start Trial   Start Trial
Jazz Pharms LUVOX CR fluvoxamine maleate CAPSULE, EXTENDED RELEASE;ORAL 022033-001 Feb 28, 2008   Start Trial   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-004 Dec 5, 1994   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Boehringer Ingelheim
Express Scripts
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.